Thorne has a new home.
What’s happening: Consumer product company Procter & Gamble is acquiring the supplement maker for $3.8B.
Bidding war. Thorne’s science-driven, premium supplements are in high demand among quality-seeking consumers — with DTC subscription revenue driving $500M in ’25 sales.
A hot commodity, when PE firm L Catterton began shopping the brand, Big CPG lined up, attracting suitors including Unilever and Haleon.
Refresh. Thorne’s precision-engineered supps bolster a P&G health division that includes fiber supplement Metamucil and Align probiotics, plus clean antacid brand Wonderbelly.
Evolving from medicine cabinet staples to daily stack, P&G will tap its acquisitions to pursue self-care, preventative health, and wellness.
Punchline: From Grüns and Huel to IM8, consumer emphasis on daily performance and functional nutrition is minting wellness unicorns — and Big CPG is on a buying spree.
